E9 Genomics is a startup based in the United States.
E9 Genomics develops Urchin, an AI-driven biological search and reasoning platform that helps biopharma teams explore large, fragmented biological data to identify novel therapeutic opportunities such as drug repurposing, target prioritization, and program strategy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.